Function of Akkermansia muciniphila in type 2 diabetes and related diseases
Effects of Akkermansia muciniphila and its derived parts on ameliorating metabolic disorders. (1) A. muciniphila-derived protein P9 directly combined with ICAM-2 and activated the GLP-1 secretion in intestinal L cells, propionate was the metabolite of A. muciniphila and also activated the GLP-1, thereby enhancing insulin secretion and alleviating hyperglycemia. (2) A. muciniphila modulated the expression of genes involved in lipid metabolism, including PPARγ, PLIN2, UCP1, ApoE, LDL. (3) A. muciniphila facilitated the transportation of L-aspartate from gut to liver, L-aspartate upregulated the LKB1-AMPK pathway and ameliorated liver steatosis. (4) A. muciniphila decreased the level of βCDCA, which was one of the FXR inhibitors, thus increasing the intestinal FGF15/19 secretion. FGF15/19 acted on multiple tissues, improved hyperlipidemia and liver steatosis. Upward aspects are indicated in black, downward aspects are indicated in red. ICAM-2, intercellular adhesion molecule 2; GLP-1, glucagon-like peptide-1; FGF15/19, fibroblast growth factor 15/19; βCDCA, 3β-chenodeoxycholic acid; FXR, farnesoid X receptor; L-asp., L-aspartate; LKB1, liver kinase B1; HDAC, histone deacetylases; UCP1, uncoupling protein 1; PLIN2, perilipin2; PPARγ, peroxisome proliferator-activated receptor gamma; LDL, low-density lipoprotein; ApoE, apolipoprotein E.
Publication
Function of Akkermansia muciniphila in type 2 diabetes and related diseases. (2023) Jinjie Li, et al. Front Microbiol. 2023;14:1172400. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | mass | MASS | ncbigene_synonym | FBN1 | 2200 |
| Homo sapiens | Primates | FGF19 | FGF19 | ncbigene_symbol | FGF19 | 9965 |
| Homo sapiens | Primates | PLIN2 | PLIN2 | ncbigene_symbol | PLIN2 | 123 |
| Homo sapiens | Primates | UCP1 | UCP1 | ncbigene_symbol | UCP1 | 7350 |
| Homo sapiens | Primates | GLP-1 | GLP-1 | ncbigene_synonym | GCG | 2641 |
| Homo sapiens | Primates | GLP-1 | GLP-1 | ncbigene_synonym | GLP1R | 2740 |
| Homo sapiens | Primates | GLP-1 | GLP-1 | ncbigene_synonym | ZGLP1 | 100125288 |
| Homo sapiens | Primates | CAM-2 | CAM2 | ncbigene_synonym | CALM1 | 801 |
| Homo sapiens | Primates | CAM-2 | CAM2 | ncbigene_synonym | CALM3 | 808 |
| Homo sapiens | Primates | CAM-2 | CAM2 | ncbigene_synonym | CAMK2B | 816 |
| Homo sapiens | Primates | LKB1 | LKB1 | ncbigene_synonym | STK11 | 6794 |
| Homo sapiens | Primates | (GLP-1) | GLP1 | ncbigene_synonym | EHMT1 | 79813 |
| Homo sapiens | Primates | ApoE | APOE | ncbigene_symbol | APOE | 348 |
| Drosophila melanogaster | Invertebrates | WAT | WAT | ncbigene_symbol | wat | 43420 |
| Drosophila melanogaster | Invertebrates | mass | MAS | ncbigene_symbol | mas | 38499 |
| Drosophila melanogaster | Invertebrates | mass | MAS | ncbigene_synonym | myoblast-specific | 49406 |
| Drosophila melanogaster | Invertebrates | PLIN2 | PLIN2 | ncbigene_synonym | Lsd-2 | 32437 |
| Drosophila melanogaster | Invertebrates | GLP-1 | GLP1 | ncbigene_synonym | GlyP | 33386 |
| Drosophila melanogaster | Invertebrates | L-asp | LASP | ncbigene_symbol | Lasp | 39864 |
| Drosophila melanogaster | Invertebrates | LKB1 | LKB1 | ncbigene_symbol | Lkb1 | 41673 |
| Drosophila melanogaster | Invertebrates | LDL | LDL | ncbigene_synonym | modSP | 42032 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Glucose | Glucose | mesh:D005947 | D-glucopyranose | chebi:4167 |
| Propionate | NA | mesh:D011422 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| WAT | NA | |||
| Steatosis | NA | mesh:D005234 |